Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR2 | O15552 | 11/20 | 0.97 |
| ▸ | CPT2 | P23786 | 1/20 | 0.38 |
| ▸ | CPT1A | P50416 | 1/20 | 0.38 |
| ▸ | CTSA | P10619 | 1/20 | 0.37 |
| ▸ | SLC12A5 | Q9H2X9 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16498339 | 1.00 | FFAR2 (0.97) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL1915824 | 0.98 | FFAR2 (1.00) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL1915829 | 0.98 | FFAR2 (1.00) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL1915491 | 0.98 | FFAR2 (0.98) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL1915492 | 0.98 | FFAR2 (0.98) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL16498179 | 0.97 | FFAR2 (0.94) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL16498182 | 0.97 | FFAR2 (0.94) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL1916702 | 0.93 | FFAR2 (0.87) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL1916704 | 0.93 | FFAR2 (0.87) | FFAR2CPT2CPT1ACTSASLC12A5 | |
| SCHEMBL16498042 | 0.91 | FFAR2 (0.86) | FFAR2CPT2CPT1ASLC12A5MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011151434-A1 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS | EUROSCREEN S.A. (BE) | 2011-12-08 | — | — | WO | claimed |
| WO-2011151434-A1 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS | EUROSCREEN S.A. (BE) | 2011-12-08 | — | — | WO | disclosed |